EVERSANA's Danny Williams breaks down the most consequential operational shifts in pharma 3PL over the past five years, from full-pallet distribution to integrated commercialization support for complex, targeted therapies.
Danny Williams
Advertisement
Danny Williams is president, channel management and 3PL, EVERSANA.
Articles by Danny Williams
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Q&A: Dr. Reddy's CEO on Generic Semaglutide and the GLP-1 Market Ahead
2
Wegovy Pill's UAE Debut Is a Distribution Story, Not Just a Market Entry
3
Cencora-Kite Agreement Signals CGT Commercialization Shift
4
Pharma Pulse: 340B Uncertainty, Drug Shortages, and Wegovy's Global Debut
5